organization · 11 records
Central Drugs Standard Control Organisation
220 drug samples fail quality tests in August 2026
A total of 220 drug samples failed quality tests in August 2026, with one case of counterfeit medication identified in Delhi.
CDSCO Issues Advisory to Curb Indiscriminate Painkiller and Antibiotic Use
The Central Drugs Standard Control Organisation has issued an advisory to curb the indiscriminate use of painkillers and antibiotics to prevent health risks.
CDSCO finds one spurious drug sample in Delhi, 220 NSQs in August
The Central Drugs Standard Control Organisation identified one spurious drug and 220 substandard samples during its August 2026 surveillance.
India plans red warning labels, school-age child pictorials on cough syrups
India is considering new mandatory red warning labels and age-specific pictorials on cough syrups to prevent usage in children under four years old.
India proposes mandatory CCTV surveillance for retail medical stores
The Indian government has proposed mandatory CCTV surveillance in retail medical stores to prevent the unauthorized sale of prescription drugs.
Dr Reddy’s bags exclusive distribution rights of Takeda’s dengue vaccine QDENGA
Takeda Pharmaceutical has signed an exclusive distribution agreement with Dr. Reddy's Laboratories to launch the dengue vaccine QDENGA in India.
12 companies bid for CDSCO’s new digital drug regulatory system
The Central Drugs Standard Control Organisation is preparing to launch a new digital regulatory system next month following bids from 12 companies.
India to receive its first dengue vaccine by 2027
India will receive its first dengue vaccine, Qdenga, in the first half of 2027 following a partnership between Dr. Reddy's Laboratories and Takeda Pharmaceutical.
India issues alert against Pakistan-made fairness creams over grave health risks
The Central Drugs Standard Control Organisation issued a public health alert against two Pakistani whitening creams containing excessive heavy metals.
Indian authorities investigate discovery of counterfeit rabies vaccines
Indian authorities are investigating the discovery of counterfeit rabies vaccines labeled as Abhayrab batch number KE25012.
Indian drug regulators flag rabies vaccine batch as substandard and potentially counterfeit
Indian drug regulators have flagged a batch of the Abhayrab rabies vaccine as substandard and potentially counterfeit after it failed potency and identity tests.